This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. The instructors will focus on a broad spectrum of flow cytometric [….]
Flow Cytometry: Principles and Methods
Single Cell RNA-Seq
This in-depth lecture and hands-on laboratory workshop (wet lab & in silica) is ideal for those research and bench scientists who are interested in a comprehensive introduction to single cell [….]
Multiplex Immunofluorescence in Immune Oncology, Workshop & Symposium
This four day program is divided into a two-day symposium with lectures presented by world class scientists in the field of immuno-oncology and with representation by all the main multiplex [….]
Flow Cytometry: Principles, Methods and Applications
This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. Developed and taught by active researchers, this workshop will focus on [….]
Top Biotech Companies Hiring in Maryland: Summer 2022 Edition
Here’s our Summer 2022 Roundup of top Maryland life sciences companies with more than 10 active job listings across a wide range of fields and experience levels.
Miltenyi Biotec Reinvests in Montgomery County with New Headquarters
Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.
Global Cell and Gene Therapy Company Miltenyi Biotec is Expanding its Operations in Maryland
BALTIMORE, MD (March 15, 2022) — Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.
“By selecting Maryland for its North American headquarters, Miltenyi Biotec will help us continue growing our industry and further our efforts in remaining one of the top 10 life sciences clusters in the nation,” said Governor Larry Hogan. “We welcome the company’s continued investment in Montgomery County and look forward to supporting their efforts in Maryland and across the globe.”
This is not the company’s first investment in Maryland in recent years. In 2014, Miltenyi Biotec acquired Gaithersburg’s lentiviral vector manufacturing company Lentigen Technology Inc., which develops and commercializes therapeutics for stem cell therapies and oncology. In 2017, the company acquired Living Pharma, Inc., a startup of the University of Maryland, Baltimore that develops personalized cell therapy for targeted individuals’ cancers and diseases. Both became part…
Biomanufacturing Career Tips for a Booming Life Sciences Market
WorkForce Genetics recently hosted the webinar event, “Navigating Your Biomanufacturing Career.” The webinar, which was held in March 2022, brought together industry thought leaders for a robust panel discussion about biomanufacturing career tips for the BioHealth Capital Region’s booming job market.
Miltenyi Biotec promotes Markus Weiss to Executive Vice President
Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.
Biotech Boom Magnifies Biomanufacturing Capacity and Workforce Challenges
The ongoing pandemic response by the biopharma industry has been historic. Biotech companies and contract development and manufacturing organizations, along with the entire supply chain, have worked together to develop several SARS-CoV-2 vaccines, achieved Emergency Use Authorization(EUA) from the FDA, and began delivering desperately needed protection into people’s arms in less than a calendar year.